100
Participants
Start Date
August 6, 2024
Primary Completion Date
March 31, 2027
Study Completion Date
March 31, 2027
Prolia
Partcipants will receive subcutaneous (SC) injections of Prolia Q6M.
RECRUITING
Peking University First Hospital, Beijing
RECRUITING
Beijing Jishuitan Hospital, Beijing
RECRUITING
The Fourth Hospital of Harbin Medical University, Harbin
RECRUITING
Shanghai Sixth Peoples Hospital, Shanghai
RECRUITING
The Second Affiliated Hospital of Nanjing Medical University, Nanjing
RECRUITING
The First Affiliated Hospital of Soochow University, Suzhou
RECRUITING
The First Peoples Hospital of Kunshan, Suzhou
RECRUITING
The Affiliated Hospital of Xuzhou Medical University, Xuzhou
RECRUITING
Xuzhou Central Hospital, Xuzhou
RECRUITING
Huaian First Peoples Hospital, Huaian
RECRUITING
Qilu Hospital of Shandong University, Jinan
RECRUITING
Jiangxi Provincial Peoples Hospital, Nanchang
RECRUITING
Pingxiang Peoples Hospital, Pingxiang
RECRUITING
The First Affiliated Hospital of Chongqing Medical University, Chongqing
RECRUITING
Sun Yat-sen Memorial Hospital Sun Yat-sen University, Guangzhou
RECRUITING
Nanfang Hospital Southern Medical University, Guangzhou
Lead Sponsor
Amgen
INDUSTRY